[1]
T. N. Popova, “Primary Cutaneous CD30+/ALK- ALCL with Transition into sALCL: Favourable Response after Systemic Administration with Brentuximab Vedotin! Unique Presentation in a Bulgarian Patient!”, Open Access Maced J Med Sci, vol. 6, no. 7, pp. 1275-1277, Jul. 2018.